Pulmonary Administration of PEGylated Polylysine Dendrimers: Absorption from the Lung versus Retention within the Lung Is Highly Size-Dependent-Reference-Cited by-同舟云学术

Pulmonary Administration of PEGylated Polylysine Dendrimers: Absorption from the Lung versus Retention within the Lung Is Highly Size-Dependent

Published:2013-06-26 Issue:8 Volume:10 Page:2986-2995
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ryan Gemma M.¹,Kaminskas Lisa M.¹,Kelly Brian D.²,Owen David J.²,McIntosh Michelle P.¹,Porter Christopher J. H.¹

Affiliation:

1. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Pde, Parkville, Victoria, Australia, 3052

2. Starpharma Pty Ltd., Baker IDI Building, Commercial Rd, Melbourne, Victoria, Australia, 3004

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp400091n

Reference38 articles.

1. The Lungs as a Portal of Entry for Systemic Drug Delivery

2. The Failure of Exubera: Are We Beating a Dead Horse?

3. Mechanisms of macromolecule absorption by the lungs

4. Allometric Relationships of Cell Numbers and Size in the Mammalian Lung

5. Biodegradable polymeric nanocarriers for pulmonary drug delivery

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-08-01

2. A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery;International Journal of Pharmaceutics;2024-06

3. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24

4. Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency;Advanced Science;2024-03-09

5. Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms;Expert Opinion on Drug Delivery;2024-01-02